Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects

Cited by (323)

Items 101–200 of 323

1. Influence of CYP2D6 Metabolizer Status on Risperidone and Paliperidone Tolerability in Children and Adolescents
   Amarachi A. Kanu, Michelle M. Johnston, Ethan A. Poweleit, Samuel E. Vaughn, Jeffrey Robert Strawn, Laura B. Ramsey · 2024 · Journal of Child and Adolescent Psychopharmacology
2. Effect of salidroside on neuroprotection and psychiatric sequelae during the COVID-19 pandemic: A review
   Ting Zhu, Hui Liu, Shiman Gao, Ning Jiang, Daiwen Chen, Weijie Xie · 2023 · Biomedicine & Pharmacotherapy
3. Drug–Drug Interactions of Selective Serotonin Reuptake Inhibitors: A Pharmacovigilance Study on Real-World Evidence from the EudraVigilance Database
   Carmen Maximiliana Dobrea, Adina Frum, Anca Butucă, Claudiu Morgovan, Laurențiu Stoicescu, Adriana Aurelia Chiş, Anca Maria Arseniu, Luca Liviu Rus, Felicia Gabriela Gligor, Andreea Loredana Vonica-Țincu · 2024 · Pharmaceuticals
4. Current and emerging pharmacotherapeutic strategies for Tourette syndrome
   Andrea E. Cavanna · 2022 · Expert Opinion on Pharmacotherapy
5. Antidepressant Effect of Alpha Lipoic Acid in Rats Exposed to Chronic Unpredictable Mild Stress: Putative Role of Neurotransmitters and 5HT3 Receptor
   Likhit Akotkar, Urmila Manoj Aswar, Rashmi Patil, Dileep Kumar, Manoj K. Aswar, Jyoti Pandey, Shailendra Shivaji Gurav · 2023 · Future Pharmacology
6. Perspectives in Psychopharmacology
   2021 · FOCUS The Journal of Lifelong Learning in Psychiatry
7. What works for mental health problems in youth? Survey of real‐world experiences of treatments and side effects
   Amy Joanna Morgan, Anna Ross, Marie B. H. Yap, Nicola Jane Reavley, Alexandra G. Parker, Magenta Bender Simmons, Faye Scanlan, Anthony Francis Jorm · 2020 · Early Intervention in Psychiatry
8. Research Progress on the Pharmacodynamic Mechanisms of Sini Powder against Depression from the Perspective of the Central Nervous System
   Zhongqi Shen, Meng Yu, Zhenfei Dong · 2023 · Medicina
9. Effects of Aripiprazole on Olanzapine Population Pharmacokinetics and Initial Dosage Optimization in Schizophrenia Patients
   Cun Zhang, Lei Jiang, Ke Hu, Liang Chen, Yi-Jia Zhang, Hao-Zhe Shi, Su‐Mei He, Xiao Chen, Dongdong Wang · 2024 · Neuropsychiatric Disease and Treatment
10. The Pharmacological Treatment of Pediatric Vertigo
    Pasquale Viola, Gianmarco Marcianò, Alessandro Casarella, Davide Pisani, Alessia Astorina, Alfonso Scarpa, Elena Siccardi, Emanuele Basile, Giovambattista De Sarro, Luca Gallelli et al. · 2022 · Children
11. Knowledge domain and trends in treatment-resistant schizophrenia (TRS) research based on CiteSpace bibliometrics analysis
    Haipeng Cai, Ruonan Du, Jianyi Zhang, Xin Yue Wang, Wei Li, Kebing Yang, Zhiren Wang · 2024 · Frontiers in Pharmacology
12. Enhancing effects of exercise and neurofeedback: A systematic review and meta-analysis of computer game-based interventions for pediatric ADHD
    Takehiko Hamada, Masaki Seki, Eishu Nango, Taro Shibata, Shinya Imai, Toshio Miyata · 2025 · Psychiatry Research
13. Cardiometabolic adverse effects of long-term antipsychotic treatment in children and adolescents with non-psychotic disorders: a systematic review of available evidence
    Ramya Padmavathy Radha Krishnan, Monika Dzidowska, Danni Zheng, Zoie Shui-Yee Wong, Nicholas Allan Buckley, Jacques Raubenheimer · 2025 · European Child & Adolescent Psychiatry
14. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) 2025 international guidelines for the management of patients with obsessive-compulsive disorder
    Michael Van Ameringen, Naomi Anne Fineberg, Arun V Ravindran, Paul Daniel Arnold, Serge Beaulieu, Vlasios Brakoulias, Elisa Macedo Brietzke, Yekta Dowlati, Lynne M. Drummond, Casara Jean Ferretti et al. · 2026 · Journal of Psychiatric Research
15. The Effects of Early-Life Stress on Liver Transcriptomics and the Protective Role of EPA in a Mouse Model of Early-Life-Stress-Induced Adolescent Depression
    Jinlan Zhao, Lihong Ye, Zuyi Liu, Jiayi Wu, Di Deng, Lin An, Shasha Bai, Lei Yang, Binjie Liu, Yafei Shi et al. · 2023 · International Journal of Molecular Sciences
16. Unlocking the power of physical activity in easing psychological distress
    Xinqiao Liu, Xin Wang · 2024 · World Journal of Psychiatry
17. Chronic Escitalopram Treatment Does Not Alter the Effects of Neonatal Stress on Hippocampal BDNF Levels, 5-HT1A Expression and Emotional Behaviour of Male and Female Adolescent Rats
    Lorena Henn, Natália C. Zanta, Carlos Eduardo Neves Girardi, Deborah Suchecki · 2020 · Molecular Neurobiology
18. Psychotropic Medication Use in Children and Adolescents With Type 1 Diabetes
    Shengxin Liu, Tyra Lagerberg, Jonas Filip Ludvigsson, Mark J. Taylor, Zheng Chang, Brian Matthew D'Onofrio, Henrik Larsson, Paul Lichtenstein, Soffia Guðbjörnsdóttir, Ralf Kuja‐Halkola et al. · 2023 · JAMA Network Open
19. Cytochrome P450 2D6 *17 and *29 Allele Activity for Risperidone Metabolism: Advancing Precision Medicine Health Equity
    Oyinlade Kehinde, Samuel E. Vaughn, Ogochukwu Ukamaka Amaeze, Paul C. Toren, Brandon Retke, Akinyemi Oni‐Orisan, Laura B. Ramsey · 2025 · Clinical Pharmacology & Therapeutics
20. Therapeutisches Drug Monitoring zur Optimierung der Psychopharmakotherapie von Kindern und Jugendlichen
    Karin Maria Egberts, Stefanie Fekete, Alexander Häge, Christoph Hiemke, Maike Scherf‐Clavel, Regina Taurines, Stefan Unterecker, Manfred Gerlach, Marcel Romanos · 2022 · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie
21. Genetic liability to bipolar disorder and body mass index: A bidirectional two‐sample Mendelian randomization study
    Lars Meinertz Byg, Maria Simonsen Speed, Doug Speed, Søren Dinesen Østergaard · 2022 · Bipolar Disorders
22. Effects of Caffeine on Main Symptoms in Children with ADHD: A Systematic Review and Meta-Analysis of Randomized Trials
    Giuliana Perrotte, Marina Maria Gonzaga Moreira, Amauri de Vargas, Alvaro Teixeira Filho, João Maurício Castaldelli-Maia · 2023 · Brain Sciences
23. An updated safety review of the current drugs for managing ADHD in children
    Erika Ryst, Ann Catherine Childress · 2023 · Expert Opinion on Drug Safety
24. Normalization and cross-sectional validation of an extended Adverse Event Profile (E AEP) in a large cohort of patients with epilepsy
    Christoph Helmstaedter, Carolin Meschede, Sandra Mastani, Susanna Moskau‐Hartmann, Michael Rademacher, Randi D. von Wrede, Juri‐Alexander Witt · 2023 · Seizure
25. The Prevalence of Hyperuricemia and the Association Between Hyperuricemia and Age in Patients with Psychiatric Disorders to a General Hospital: A Cross-Section Study
    Guodong Yang, Shuang Zhou, Yue Feng, Jiaran Lang, Yaxin Chen, Huipeng Ren · 2024 · International Journal of General Medicine
26. The protective effect of S-adenosylmethionine on chronic adolescent stress-induced depression-like behaviors by regulating gut microbiota
    Jingjing Xu, Xinqi Wang, Wangwang Xu, Yang Zhang, Liangke Pan, Jin Dong Gao · 2024 · European Journal of Pharmacology
27. Kidney plays an important role in ketogenesis induced by risperidone and voluntary exercise in juvenile female rats
    Weijie Yi, Emma Sylvester, Jiamei Lian, Chao Deng · 2021 · Psychiatry Research
28. Adverse childhood experiences (ACEs), psychotropic medication prescription, and continued offending among youth with serious offending histories in juvenile justice residential placement
    Kevin T. Wolff, Michael T. Baglivio, Jonathan Intravia · 2022 · Journal of Criminal Justice
29. There is no health without mental health: Challenges ignored and lessons learned
    Alvina Grace Lai, Wai Hoong Chang · 2022 · Clinical and Translational Medicine
30. Identifying factors related to sertraline concentrations in child/adolescent and adult patients: insights from a therapeutic drug monitoring service
    Ruoming Li, Bin Bi, Zhe Dong, Sai Chen, Yuan Yun, Hasenqimuge, Hasenqimuge, Song Chen, Yunlong Tan · 2025 · BMC Psychiatry
31. Neurological Adverse Effects of Antipsychotic Medication in Children and Young People
    Frank Besag, Michael J. Vasey, Chris P. Hollis, David M. Taylor · 2026 · Pediatric Drugs
32. Digital Lifestyle Interventions for Young People With Mental Illness: A Qualitative Study Among Mental Health Care Professionals
    Chelsea S. Sawyer, Rebekah Carney, Lamiece Hassan, Sandra Bucci, John Sainsbury, Karina Lovell, John Blake Torous, Joseph Firth · 2024 · JMIR Human Factors
33. Effectiveness of Omega-3 Fatty Acids Versus Placebo in Subjects at Ultra-High Risk for Psychosis: The PURPOSE Randomized Clinical Trial
    Inge Winter-van Rossum, Margot I. E. Slot, Hendrika H. van Hell, Matthijs Geert Bossong, Gregor Emanuel Berger, Harald N. Aschauer, Arija Maat, Susanne Walitza, Orly Lavan, Inmaculada Baeza et al. · 2024 · Schizophrenia Bulletin
34. Latent Sex Differences in CaMKII-nNOS Signaling That Underlie Antidepressant-Like Effects of Yueju-Ganmaidazao Decoction in the Hippocampus
    Ying Yin, Shiyu Qian, Yifan Chen, Yan Sun, Yuqiao Li, Yongfei Yu, Jianqing Li, Zhangjie Wu, Xinlang Yu, Rui Ge et al. · 2021 · Frontiers in Behavioral Neuroscience
35. Treatment Approaches for First Episode and Early-Phase Schizophrenia in Adolescents and Young Adults: A Delphi Consensus Report from Europe
    Christoph Ulrich Correll, Paolo Fusar‐Poli, Stefan Leucht, Anne Karow, Nadja P. Marić, Carmen Moreno, Merete Nordentoft, Andrea Raballo · 2022 · DOAJ (DOAJ: Directory of Open Access Journals)
36. Promises and Pitfalls of NMDA Receptor Antagonists in Treating Violent Aggression
    Caitlyn J. Bartsch, Jacob C. Nordman · 2022 · Frontiers in Behavioral Neuroscience
37. Wait No Longer: Reducing Medication Wait-Times for Individuals with Co-Occurring Disorders
    James H. Ford, Deepika Rao, Aaron M. Gilson, Arveen Kaur, Hélène Chokron Garneau, Lisa Saldana, Mark P. McGovern · 2022 · Journal of Dual Diagnosis
38. Lithium use in childhood and adolescence, peripartum, and old age: an umbrella review
    Delfina Janiri, Gaia Sampogna, Umberto Albert, Filippo Caraci, Giovanni Martinotti, Gianluca Serafini, Alfonso Antonio Vincenzo Tortorella, Alessandro Zuddas, Andrea Fiorillo, Gabriele Sani · 2023 · International Journal of Bipolar Disorders
39. Pediatric Toxicology
    Uttam C Garg, Stephen L. Thornton · 2025 · Clinics in Laboratory Medicine
40. Epilepsy and psychosis: navigating through a complex intersection
    Marco Mula, Andres M. Kanner, Allan Hunter Young, Annabella Di Giorgio, Andreas Schulze‐Bonhage, Eugen Trinka · 2025 · BJPsych Open
41. Metformin for overweight and obese children and adolescents with bipolar spectrum and related mood disorders treated with second-generation antipsychotics: a randomised, pragmatic trial
    Melissa P. DelBello, Jeffrey A. Welge, Christina C. Klein, Thomas J. Blom, Victor Fornari, Claudine Higdon, Michael T. Sorter, Brian Perry Kurtz, Cindy Starr, Andrew Smith et al. · 2025 · The Lancet Psychiatry
42. Clinical Practice Guideline on the Choice of First Antipsychotic Medicine for Females Experiencing a First-Episode of Psychosis
    Caroline Hynes-Ryan, Dolores Keating, Aoife Carolan, Bodyl A. Brand, Paola Dazzan, Fiona Gaughran, Margaret Hahn, Sean Halstead, Sophie Mae Harrington, Yvonne Hartnett et al. · 2026 · Schizophrenia Bulletin
43. Recognizing, Managing and Treating Acute Agitation in Youths
    Virginio Salvi, Laura Orsolini, Lorenzo Maria Martino, Simone Pompili, Umberto Volpe · 2022 · Current Pharmaceutical Design
44. Vitamin D Deficiency and Risk Factors Related to Acute Psychiatric Relapses in Patients with Severe Mental Disorders: A Preliminary Study
    Michele Fabrazzo, Salvatore Agnese, Salvatore Cipolla, Matteo Di Vincenzo, Emiliana Mancuso, Antonio Volpicelli, Francesco Perris, Gaia Sampogna, Francesco Catapano, Andrea Fiorillo et al. · 2022 · Brain Sciences
45. Review of Pharmacogenomics of Psychiatric Comorbidities in Autism Spectrum Disorder
    Aida Álvarez Pedrero, Valentin Bote, Cristina Lamborena, Raquel Medina, Alex Serra-Llovich, Amaia Hervas G, Maria Jesús Arranz · 2023 · Pharmacogenomics
46. Lack of transparency on baseline pharmacological treatments in Clinical High-Risk for psychosis (CHR-P) may degrade precision: A systematic review and meta-analysis
    Andrea Raballo, Michele Poletti, Antonio Preti · 2025 · European Neuropsychopharmacology
47. Prescriptions of Antipsychotics in Younger and Older Geriatric Patients with Polypharmacy, Their Safety, and the Impact of a Pharmaceutical-Medical Dialogue on Antipsychotic Use
    Eva-Maria Gebauer, Albert Lukas · 2022 · Biomedicines
48. Antipsychotic and antidepressant prescribing for 704 297 children and young people with and without intellectual disabilities: record linkage study
    Angela Henderson, Deborah Cairns, Michael Fleming, Bethany Stanley, Nicola Greenlaw, Genevieve Young‐Southward, Jill P. Pell, Sally‐Ann Cooper · 2020 · The British Journal of Psychiatry
49. Psychotropic Medication Prescribing in a Juvenile Justice Facility: Evidence of a Limited Discontinuation Process
    Ashley N. Anderson, John T. Rapp, Erica D. Kierce · 2021 · Residential Treatment for Children & Youth
50. Long-term safety and effectiveness of open-label lurasidone in antipsychotic-Naïve versus previously treated adolescents with Schizophrenia: A post-hoc analysis
    Christoph Ulrich Correll, Michael Tocco, Andrei Pikalov, Jay Hsu, ROBERT S. GOLDMAN · 2022 · Schizophrenia Research
51. Prevalence of Heavy Menstrual Bleeding and Its Associated Cognitive Risks and Predictive Factors in Women With Severe Mental Disorders
    Jianmin Shan, Hongjun Tian, Chunhua Zhou, Haibo Wang, Xiaoyan Ma, Ranli Li, Haiping Yu, Guangdong Chen, Jingjing Zhu, Ziyao Cai et al. · 2022 · Frontiers in Pharmacology
52. Timing of antipsychotics and benzodiazepine initiation during a first episode of psychosis impacts clinical outcomes: Electronic health record cohort study
    Maite Arribas, Marco Solmi, Trevor Thompson, Dominic Oliver, Paolo Fusar‐Poli · 2022 · Frontiers in Psychiatry
53. Weight Gain During Antipsychotic Treatment in Children, Adolescents, and Adults: A Disproportionality Analysis in the Global Pharmacovigilance Database, Vigibase®
    Florentia Kaguelidou, Zaba Valtuille, Geneviève Durrieu, Richard Delorme, Hugo Peyre, Jean‐Marc Tréluyer, François Montastruc, Laurent Chouchana · 2022 · Drug Safety
54. Frequency of binge eating in medication adherent patients with ADHD and its relation to impulsivity
    Shaker, Nermin Mahmoud, Mahmoud, Dalia Abdel Moneim, Ahmed, Mohamed Mahmoud, Rabie, Eman S. · 2025 · Middle East Current Psychiatry
55. Adverse events of pharmacological interventions for insomnia disorder in adults: a systematic review and network meta-analysis
    Changhong Lu, Yuanyuan Geng, Xiaoli Guan, Ying Meng, Mucheng Zhu, Yuan Zhao · 2025 · Frontiers in Psychiatry
56. Fluoxetine exerts anti‐inflammatory effects on human epidermal keratinocytes and suppresses their endothelin release
    Kinga Fanni Tóth, Dorottya Ádám, József Arany, Yesid A. Ramírez, Tamás Bı́ró, Jennifer I. Drake, Alison O’Mahony, Attila Gábor Szöllősi, Szilárd Póliska, Ana Kilić et al. · 2023 · Experimental Dermatology
57. Systematic Review and Meta-Analysis: Placebo Response in Randomized Controlled Trials of Tourette’s Disorder Medications
    Pedro Macul Ferreira de Barros, Luís C. Farhat, Emily Behling, Madeeha Nasir, Angeli Landeros‐Weisenberger, Michael H. Bloch · 2024 · Journal of the American Academy of Child & Adolescent Psychiatry
58. Exploring the potential association between stimulant or atomoxetine use and suicidal or self-injurious behaviors in children with attention deficit hyperactivity disorder: real-world insights from the FAERS database
    Jinhua Liu, Liping Xue, Fanxiang Zeng, Liu Ying, Yanting Zhu, Jintuo Zhou, Jinhua Zhang, Huajiao Chen · 2025 · European Child & Adolescent Psychiatry
59. Emergence of psychiatric adverse events during antipsychotic treatment in AP-naïve children and adolescents
    Marie-Line Ménard, Philippe Auby, Coralie Cruzel, David Cohen, Olivier Bonnot, Florence Askenazy-Gittard, Susanne Thümmler, ETAPE Study Group, Boublil Michel, Castaings Agnès et al. · 2022 · Child and Adolescent Psychiatry and Mental Health
60. Attention deficit hyperactivity disorder, physical abuse and methylphenidate treatment in children
    Kenneth K. C. Man, Le Gao, Wallis C. Y. Lau, Min Fan, David Coghill, Esther W. Chan, Celine Sze Ling Chui, Xue Li, Adrienne Y L Chan, Terry Y S Lum et al. · 2023 · Nature Mental Health
61. Treatment with methylphenidate and the risk of fractures among children and young people: A systematic review and self‐controlled case series study
    Le Gao, Kenneth K. C. Man, Min Fan, Grace Mengqin Ge, Wallis C. Y. Lau, Ching‐Lung Cheung, David Coghill, Patrick Ip, Kirstie H. T. W. Wong, Ian Chi Kei Wong · 2023 · British Journal of Clinical Pharmacology
62. Antidepressant activity of flavones from traditional Chinese medicine: a meta-analysis
    Qing Wang, Youyuan Lu, Xue Mi, Cai-Yan Yang, Ma Wei, Changbo Xia, Hanqing Wang · 2025 · Pharmaceutical Biology
63. Antidepressant effects of cherry leaf decoction on a chronic unpredictable mild stress rat model based on the Glu/GABA-Gln metabolic loop
    Chuan Jiang, Hua Wang, Jiaying Qi, Jinghan Li, Qianqian He, Chaonan Wang, Yonggang Gao · 2022 · Metabolic Brain Disease
64. Child and adolescent psychiatry: challenges, solutions, opportunities, and future directions
    Cortese, Samuele, Arango, Celso, Aymerich, Claudia, Catalan, Ana, Chetouani, Mohamed, Cohen, David, Coghill, David, Gabellone, Alessandra, Iniesta, Raquel, Kadan, Anoop et al. · 2026 · World Psychiatry
65. Analysis of the status of drug treatment in 746 inpatients with early-onset schizophrenia in China: a retrospective study
    Jiuping Zhang, Xin Cheng, Huihui Zhang, Ping Xu, Peiying Jin, Xiaoyan Ke · 2021 · BMC Psychiatry
66. Efficacy and Safety of Lurasidone in Children and Adolescents: Recommendations for Clinical Management and Future Research
    Andrea Amerio, Costanza Giacomini, Laura Fusar‐Poli, Andrea Aguglia, Alessandra Costanza, Gianluca Serafini, Eugenio Aguglia, Mario Amore · 2021 · Current Pharmaceutical Design
67. The use of psychotropic medications in autistic individuals (21 years and younger) in Western Australia: A preliminary investigation
    Roselyne Bulonza, Kim Watkins, Richard Whaddon Parsons, Bruce Sunderland, Andrew Whitehouse, Rima Caccetta · 2024 · Autism
68. Noradrenergic Projections from the Locus Coeruleus to the Medial Prefrontal Cortex Enhances Stress Coping Behavior in Mice Following Long-Term Intermittent Fasting
    Zheng Zhao, Junliang Chen, Han Zhan, Chang-Rong Fang, Libo Hua, Hao-Yuan Deng, Zongqin Xiang, Ying Yang, Lang Huang, Yong Liu · 2024 · NeuroMolecular Medicine
69. Association between intake of various sugar subtypes and common mental disorders: A large prospective study
    Lina Qin, Boyue Zhao, Meijuan Kang, Tingting Mao, Weixuan Da, Yue Che, Hanchi Wang, Yijia Li, Jin Feng, Yifan Gou et al. · 2025 · The journal of nutrition health & aging
70. Clinical high at-risk mental state in young subjects accessing a mental disorder prevention service in Italy
    Enrico Monego, Carla Cremonese, Federica Gentili, Paolo Fusar‐Poli, Jai L. Shah, Marco Solmi · 2022 · Psychiatry Research
71. Extended childhood disorder (ECD): Proposal and preliminary empirical support for a new ecologically-based diagnostic category of teen dysfunction
    Robert Epstein, Savannah Aries, Theodore T. Caligiuri, Camille Karner · 2025 · International Journal of Clinical and Health Psychology
72. Lurasidone induces developmental toxicity and behavioral impairments in zebrafish embryos
    Wentian Li, Fang Wang, Zhe Feng, Qianqian Cheng, Yuqing Huang, Lisheng Zhu, Xiao Han, Hongjian Gong · 2025 · Frontiers in Psychiatry
73. A case report of attention deficit hyperactivity disorder in preschool children treated with individualised, constitutional homoeopathic medicine
    Karunakara Moorthi, K Lalitha · 2024 · Indian Journal of Research in Homoeopathy
74. Fluoxetine exerts anti-proliferative effect in human epidermal keratinocytes
    Dorottya Ádám, József Arany, Kinga Fanni Tóth, Szilárd Póliska, Judit Váradi, Péter Kolozsi, Dezső Tóth, Hanna Niehues, Ellen H. J. van den Bogaard, Michael Soeberdt et al. · 2025 · Archives of Dermatological Research
75. Safety Outcomes from a Long-Term, Prospective Study of Sertraline Use in Children and Adolescents: The Sertraline Pediatric Registry for the Evaluation of Safety
    Sara Ramaker, Francesca Kolitsopoulos, Lisa Ludwig, Scott N. Compton, Samuel Broderick, John Orazem, Weihang Bao, Yuliya V. Lokhnygina, Sarah Hackley, Phillip B. Chappell · 2025 · Journal of Child and Adolescent Psychopharmacology
76. From adventures to diagnosis: adolescent behavior in classic fiction through the eyes of newly licensed Czech psychiatrists – a vignette study
    Vojtěch Pišl, Andrea Hodkova, Jiřı́ Hudeček, Marek Páv, Jan Vevera · 2025 · Frontiers in Psychiatry
77. How to identify depression and anxiety in children and adolescents
    Coraima Beatriz Anaya Linan, Gibsi MP Rocha, Marta Knijnik Lucion · 2025 · Jornal de Pediatria
78. Korean Medication Algorithm Project for Depressive Disorder 2021 (III): Child and Adolescent
    Chan-Mo Yang, Se-Hoon Shim, Won‐Myong Bahk, Young Sup Woo, Jong‐Hyun Jeong, Sheng‐Min Wang, Won Kim, Jeong Seok Seo, Jung Goo Lee, Young‐Min Park et al. · 2021 · 신경정신의학
79. Successful Treatment of Tourette Syndrome With a Combination of Guanfacine and Aripiprazole: A Case Series
    Tikku George, Mallory Emig, Pratap Chand, Heer Hendry · 2023 · Cureus
80. Abnormal blood lipid and electrocardiogram characteristics in common mental disorders
    Yan Li, Chaohua Tang, Weibo Wu, Zhijian Li, Xuesong Li, Wei Huang, Wensheng Chen, Xiancong Mai, Xiaoling Li, Caixia Xu et al. · 2023 · BMC Psychiatry
81. Associations Between Dysregulation and Metabolic Syndrome in Youth and Adults
    Merelise R. Ametti, Aya Cheaito, Hannah E. Frering, Philip A. Ades, Christopher David, Robert R. Althoff · 2023 · JAACAP Open
82. Repositioning pinacidil and its anticonvulsant and anxiolytic properties in murine models
    Artur Teixeira Pereira, Erica Aparecida Gelfuso, René Oliveira Beleboni · 2024 · Scientific Reports
83. Autism Spectrum Disorder
    Donald E. Greydanus, Dilip R. Patel, Dustin C. Rowland · 2021 · Elsevier eBooks
84. Children and Adolescents
    2021 · Wiley eBooks
85. Brain Network Homeostasis and Plasticity of Salidroside for Achieving Neuroprotection and Treating Psychiatric Sequelae Stemming from Stress
    Ting Zhu, Hui Liu, Shiman Gao, Daiwen Chen, Ning Jiang, Weijie Xie · 2023 · Research Square
86. Distinguishing different psychiatric disorders using DDx-PRS
    Wouter J. Peyrot, Georgia Panagiotaropoulou, Loes M. Olde Loohuis, Mark J. Adams, Swapnil Awasthi, Tian Ge, Andrew Mark McIntosh, Brittany L. Mitchell, Niamh Mullins, Kevin Sean O’Connell et al. · 2024 · medRxiv
87. Is higher physical activity behaviour associated with less subsequent use of any psychotropic medication: Results of a random-effects meta-analysis of prospective cohort studies
    Sebastian Wolf, Edith Meinzinger, Anna Katharina Frei, Britta Seiffer, Johanna Löchner, Keisuke Takano, Siobhán Scarlett, Rose Anne Kenny, Viviane Derhon, Maria Eduarda Adornes Guimarães et al. · 2024 · Mental health and physical activity
88. Antipsychotics and dietary interventions: Pharmacodynamics, pharmacokinetics, and synergisms in therapy
    Cristiana Perrotta, Carla Carnovale, Marco Pozzi, Clara De Palma, Davide Cervia, Maria Nobile, Emilio Clementi · 2025 · Pharmacological Reviews
89. The efficacy and safety of pharmacological treatment for major depressive episode with mixed features specifier: a systematic review and meta-analysis
    Sirui Gao, Yanjun Chen, Jin Liu, Qianqian Zhang, Xiaotian Zhao, Bangshan Liu, Yan Zhang, Lingjiang Li, Gang Wang · 2025 · Psychological Medicine
90. The real-world safety profile of amitriptyline: A comprehensive pharmacovigilance analysis based on the large-scale FDA adverse event reporting system database
    Ying Yang, Yanhua Xie, Liangjuan Hou, Xiang Liu · 2026 · Neurotherapeutics
91. Acupuncture for emotional disorders in patients with inflammatory bowel disease: a systematic review protocol
    Yuanfang Zhou, Guilong Zhang, Ning Sun, Zhongquan Wang, Xiangyin Ye, Jian Ping Xiong, Xiao‐Dong Deng, Xin Lin, Pei Zhang, Hao Zheng et al. · 2022 · BMJ Open
92. Adverse events in cognitive behavioral therapy and relaxation training for children and adolescents with obsessive-compulsive disorder: A mixed methods study and analysis plan for the TECTO trial
    Linea Pretzmann, Sofie Heidenheim Christensen, Anne Bryde Christensen, Camilla Funch Uhre, Valdemar Uhre, Christine Lykke Thoustrup, Iben Thiemer Clemmesen, Tin Aaen Gudmandsen, Nicoline Løcke Jepsen Korsbjerg, Anna‐Rosa Cecilie Mora‐Jensen et al. · 2023 · Contemporary Clinical Trials Communications
93. Comparative Effects of Stimulant and Antipsychotic Medications on Eating Behaviors and Weight in Children with Attention Deficit Hyperactivity Disorder
    Hasan Cem Aykutlu, Esra Okyar, Mehmet Karadağ, Masum Öztürk · 2024 · Children
94. Agomelatine in pediatric patients with moderate to severe major depressive disorder: an open-label extension study
    Celso Arango, Jörg Michael Fegert, Françoise Picarel-Blanchot, Ute Marx, Lucie Truffaut-Chalet, Pierre‐François Pénélaud, Jan K. Buitelaar, the study investigators · 2024 · European Child & Adolescent Psychiatry
95. Comparing and intervening on behavioral demand for snack foods among justice‐involved adolescents: A preliminary translational analysis
    Anna Kate Edgemon, Carla N. Martinez‐Perez, M. Christopher Newland, John T. Rapp · 2024 · Journal of the Experimental Analysis of Behavior
96. Efficacy of Lurasidone in First-Episode Psychosis: Patient Phenotypes, Dosage, and Recommendations from an Expert Panel
    Miquel Bernardo, Marina Díaz‐Marsá, Ana María González-Pinto, Manuel Martín Carrasco, Víctor Pérez, Pilar Alejandra Sáiz, Eduard Vieta, Marta Torrens, Celso Arango, Benedicto Crespo‐Facorro · 2025 · Neurology and Therapy
97. The Use and Side Effect Profile of Valproate and Lamotrigine in Child and Adolescent Psychiatry
    Yeşim Sağlam, Kübra TURAN, Şükret ALEV, Gül Karaçetin · 2025 · Namık Kemal Tıp Dergisi
98. Preventive intervention for depression in children, adolescents and adults
    Disciplina Medicină de familie, Universitatea de Medicină și Farmacie „Carol Davila“, București, România, Ana Maria Alexandra Stănescu, Anca Angela SIMIONESCU, Disciplina Obstetrică-Ginecologie,, Universitatea de Medicină și Farmacie “Carol Davila”, București, România, Ioana Veronica Grăjdeanu, Disciplina Medicină de familie, Universitatea de Medicină și Farmacie „Iuliu Hațieganu“, Cluj-Napoca, România, Mira Florea, Disciplina Medicină de familie, Universitatea de Medicină și Farmacie „Iuliu Hațieganu“, Cluj-Napoca, România · 2021 · Romanian Journal of Medical Practice
99. Psiquiatría y evidencia: lecciones de la pandemia
    2020 · Revista de Psiquiatría del uruguay
100. Risk-to-befit ratios of consecutive antidepressants for heavy menstrual bleeding in young women with bipolar disorder or major depressive disorder
     Chuanjun Zhuo, Guangdong Chen, Chongguang Lin, Jing Ping, Jingjing Zhu, Lina Wang, Shili Jin, Chuanxin Liu, Qiuyu Zhang, Lei Yang et al. · 2022 · Frontiers in Psychiatry